| First Author | Solomou K | Year | 2002 |
| Journal | Eur J Immunol | Volume | 32 |
| Issue | 6 | Pages | 1550-9 |
| PubMed ID | 12115637 | Mgi Jnum | J:77091 |
| Mgi Id | MGI:2180988 | Doi | 10.1002/1521-4141(200206)32:6<1550::AID-IMMU1550>3.0.CO;2-W |
| Citation | Solomou K, et al. (2002) Somatostatin is expressed in the murine thymus and enhances thymocyte development. Eur J Immunol 32(6):1550-9 |
| abstractText | A functional interaction between the immune and the nervous system has been suggested, with neuropeptides acting as immunomodulators. Somatostatin (SOM) is a neuropeptide, mainly produced in the brain, that binds to five different receptors (SSTR). It is believed that SOM along with one of its receptors, SSTR2, is expressed in the murine thymus, although their exact localization is unresolved. We found that SOM is highly expressed in both cortical and medullary epithelial cells whereas its receptor SSTR2 is expressed on thymocytes. In order to elucidate its role in thymopoiesis, SOM was added in fetal thymic organ culture (FTOC) and found to increase thymocyte numbers and enhance maturation. SOM increased the cellular proliferation of total splenocytes but inhibited proliferation of thymocytes and purified splenic T cells. Furthermore, SOM was able to induce the migration of thymocytes. We also investigated the effect of four other neuropeptides in FTOC and found that, vasoactive intestinal peptide had a marginal effect, whereas substance P increased thymic cellularity, at intermediate but not at low or high concentrations. In contrast, both neuropeptide Y and calcitonin gene-related peptide reduced thymocyte numbers. This study supports the hypothesis for a role of neuropeptides, particularly somatostatin, in immune regulation and development. |
